预测临床实践中癫痫持续状态终止的因素:SENSE前瞻性观察登记研究
该研究在德国、奥地利和瑞士的前瞻性观察登记中分析了1,049例成人癫痫持续状态(SE)患者,发现临床实践中常未遵循指南推荐剂量。多变量Cox回归显示,以苯二氮䓬类药物作为初始治疗及早期较高累积抗惊厥药剂量与SE终止时间缩短相关。
要点
- 临床实践中76%的全面性惊厥性SE和78%的非全面性惊厥性SE患者首剂剂量低于指南推荐。
- 以苯二氮䓬类作为初始治疗与SE终止时间缩短相关。
- 早期较高累积抗惊厥药剂量与SE终止时间缩短相关。
核心结论
- 临床实践中相当比例患者未遵循治疗指南,剂量不足与SE未终止相关。
- 数据提示应使用剂量充足的苯二氮䓬类药物作为初始治疗。
研究设计与样本
- 前瞻性观察登记研究(SENSE),纳入德国、奥地利和瑞士中心4.5年内治疗的成人SE患者。
- 分析1,049例患者的发作事件,采用单变量和多变量统计确定SE终止的预测因素。
主要发现
- SE起病中位年龄70岁,最常见病因分别为远期症状性(32%)和急性症状性(31%)。
- 全面性惊厥性SE占43%;GCSE从起病到首次治疗的中位延迟为30分钟,非GCSE为150分钟。
- GCSE患者中86%首次静脉用药为苯二氮䓬类,非GCSE患者中为73%。
- 319例GCSE患者(70%)在开始治疗后1小时SE仍在持续,342例非GCSE患者(58%)在开始治疗后12小时SE仍在持续。
- 多变量Cox回归显示,以苯二氮䓬类作为初始治疗及早期较高累积抗惊厥药剂量与两组SE终止时间缩短相关。
关键数值与推荐
- GCSE患者首剂剂量低于指南推荐者占76%,非GCSE患者占78%。
- SE终止判定:GCSE为开始治疗后1小时内,非GCSE为开始治疗后12小时内。
临床怎么用
- 临床应遵循指南,使用剂量充足的苯二氮䓬类药物作为SE初始治疗。
- 需关注早期累积抗惊厥药剂量,避免剂量不足导致SE持续。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the initial termination rate of status epilepticus (SE) in a large observational study and explore associated variables. METHODS: Data of adults treated for SE were collected prospectively in centers in Germany, Austria, and Switzerland, during 4.5 years. Incident episodes of 1,049 patients were analyzed using uni- and multivariate statistics to determine factors predicting cessation of SE within 1 hour (for generalized convulsive SE [GCSE]) and 12 hours (for non-GCSE) of initiating treatment. RESULTS: Median age at SE onset was 70 years; most frequent etiologies were remote (32%) and acute (31%). GCSE was documented in 43%. Median latency between SE onset and first treatment was 30 minutes in GCSE and 150 minutes in non-GCSE. The first intravenous compound was a benzodiazepine in 86% in GCSE and 73% in non-GCSE. Bolus doses of the first treatment step were lower than recommended by current guidelines in 76% of GCSE patients and 78% of non-GCSE patients. In 319 GCSE patients (70%), SE was ongoing 1 hour after initiating treatment and in 342 non-GCSE patients (58%) 12 hours after initiating treatment. Multivariate Cox regression demonstrated that use of benzodiazepines as first treatment step and a higher cumulative dose of anticonvulsants within the first period of treatment were associated with shorter time to cessation of SE for both groups. INTERPRETATION: In clinical practice, treatment guidelines were not followed in a substantial proportion of patients. This underdosing correlated with lack of cessation of SE. Our data suggest that sufficiently dosed benzodiazepines should be used as a first treatment step. ANN NEUROL 2019;85:421-432.
引用
- Kellinghaus C, Rossetti AO, Trinka E, et al. Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE). Ann Neurol. 2019. PMID: 30661257. doi:10.1002/ana.25416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。